These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 33540334)
41. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design. Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857 [TBL] [Abstract][Full Text] [Related]
42. Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities. Patil K; Bagade S; Bonde S; Sharma S; Saraogi G Biomed Pharmacother; 2018 Mar; 99():735-745. PubMed ID: 29710471 [TBL] [Abstract][Full Text] [Related]
43. Global clinical trials for the treatment of TB with thioridazine. Boeree MJ Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):99-103. PubMed ID: 21548879 [TBL] [Abstract][Full Text] [Related]
44. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855 [TBL] [Abstract][Full Text] [Related]
45. Therapeutic drug monitoring in the treatment of tuberculosis: an update. Alsultan A; Peloquin CA Drugs; 2014 Jun; 74(8):839-54. PubMed ID: 24846578 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and bioactivity of antitubercular peptides and peptidomimetics: an update. De Leon Rodriguez LM; Kaur H; Brimble MA Org Biomol Chem; 2016 Jan; 14(4):1177-87. PubMed ID: 26645944 [TBL] [Abstract][Full Text] [Related]
48. Synthetic investigational new drugs for the treatment of tuberculosis. Kwon YS; Koh WJ Expert Opin Investig Drugs; 2016; 25(2):183-93. PubMed ID: 26576631 [TBL] [Abstract][Full Text] [Related]
49. Opportunities and challenges of using five-membered ring compounds as promising antitubercular agents. Yan M; Xu L; Wang Y; Wan J; Liu T; Liu W; Wan Y; Zhang B; Wang R; Li Q Drug Dev Res; 2020 Jun; 81(4):402-418. PubMed ID: 31904877 [TBL] [Abstract][Full Text] [Related]
50. Recommendations for treating children with drug-resistant tuberculosis. Galli L; Lancella L; Garazzino S; Tadolini M; Matteelli A; Migliori GB; Principi N; Villani A; Esposito S; Pharmacol Res; 2016 Mar; 105():176-82. PubMed ID: 26821118 [TBL] [Abstract][Full Text] [Related]
51. 4H-1,3-Benzothiazin-4-one a Promising Class Against MDR/XDR-TB. de Souza MVN; Nogueira TCM Curr Top Med Chem; 2019; 19(8):567-578. PubMed ID: 30834835 [TBL] [Abstract][Full Text] [Related]
52. Trench warfare in a battle with TB. Marshall E Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790 [No Abstract] [Full Text] [Related]
53. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
55. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis. Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491 [TBL] [Abstract][Full Text] [Related]
56. Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed Therapies. Borah P; Deb PK; Venugopala KN; Al-Shar'i NA; Singh V; Deka S; Srivastava A; Tiwari V; Mailavaram RP Curr Top Med Chem; 2021; 21(6):547-570. PubMed ID: 33319660 [TBL] [Abstract][Full Text] [Related]
57. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing. Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132 [TBL] [Abstract][Full Text] [Related]
58. Management of multidrug resistant tuberculosis. Daley CL; Caminero JA Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005 [TBL] [Abstract][Full Text] [Related]
59. Stereochemistry at the forefront in the design and discovery of novel anti-tuberculosis agents. Huang Q; He R; Kozikowski AP Curr Top Med Chem; 2011; 11(7):810-8. PubMed ID: 21291395 [TBL] [Abstract][Full Text] [Related]
60. Resistance to anti-tuberculosis medications in the Horn of Africa. Ollé-Goig JE; Codina-Grau G; Martín-Casabona N Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]